Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.0%

3 terminated/withdrawn out of 23 trials

Success Rate

78.6%

-7.9% vs industry average

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

73%

8 of 11 completed trials have results

Key Signals

6 recruiting8 with results

Enrollment Performance

Analytics

N/A
5(71.4%)
Phase 4
2(28.6%)
7Total
N/A(5)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT07479433Recruiting

The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI

Role: lead

NCT06205810Recruiting

The COMPLETE Study

Role: collaborator

NCT06376851Active Not Recruiting

AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management

Role: lead

NCT06506448Recruiting

Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease

Role: collaborator

NCT01943903Completed

The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)

Role: lead

NCT06603363Not ApplicableRecruiting

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

Role: collaborator

NCT06831409Recruiting

Using CTA Measures to Define Cardiac Risk In NFL Alumni

Role: lead

NCT05138289Completed

The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

Role: lead

NCT02499679Completed

Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care

Role: lead

NCT04761991Recruiting

CMR Versus CT in Coronary Artery Disease

Role: collaborator

NCT05368545Not ApplicableCompleted

Influence of Lipid Lowering on Impaired Coronary Flow

Role: collaborator

NCT04864119Completed

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

Role: collaborator

NCT03702244Not ApplicableCompleted

The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

Role: lead

NCT03026283Completed

The Value of CT Fractional Flow Reserve

Role: collaborator

NCT05325112Terminated

Assessing Diagnostic Value of Non-invasive FFR-CT (Fractional Flow Reserve - Computed Tomography) in Coronary Care in the Emergency Department

Role: lead

NCT04142021Unknown

Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)

Role: collaborator

NCT01233518Not ApplicableCompleted

Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

Role: lead

NCT03851276Phase 4Withdrawn

A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT.

Role: collaborator

NCT03851263Phase 4Withdrawn

Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion

Role: collaborator

NCT02813473Completed

SYNTAX III REVOLUTION Trial: A Randomized Study Investigating the Use of CT Scan and Angiography of the Heart to Help the Doctors Decide Which Method is the Best to Improve Blood Supply to the Heart in Patients With Complex Coronary Artery Disease

Role: collaborator